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program while repressing Bcl-6 (a
transcription factor essential for Tfh
development), could TCR signal strength
dictate differential programming through
this mechanism? What is the relationship,
if any, between TCR signal strength
and ICOS signaling, which also promotes
Tfh development? Finally, what are impli-
cations for the quality of the antibody
response controlled by Tfh cells or devel-
opment of CD4 T cell memory? In view of
data supporting development of CD4
memory T cells from Tfh precursors
(Choi et al., 2013; Pepper et al., 2011),
does initial TCR signaling serve to direct
alternative effector and memory CD4
T cell fates, and if so, might this translate
into memory populations with differing
recall characteristics? Clearly, much
work remains to be done. In the mean-time, this study highlights once more the
remarkable capacity of naive T cells to
integrate a diversity of input gradients
from both the TCR and non-TCR recep-
tors to direct alternative programs of
differentiation.REFERENCES
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Daily metabolic patterns are regulated in a circadian manner often via the hypothalamic axis.
Mukherji et al. now report a surprising role for commensal bacteria in the circadian regulation of
glucocorticoid production by intestinal epithelial cells.Glucocorticoid synthesis by intestinal
epithelial cells (IECs) is a well-known
example of a process regulated in a
circadian manner, with its production
being high during the active phase and
decreased during the resting period
(Asfeldt, 1971). Previous research has
mainly focused on the role of the hypo-
thalamic-pituitary-adrenal (HPA) axis in
controlling this daily pattern of production
(Kino, 2012). In this issue, Pierre Cham-
bon and colleagues (Mukherji et al.,
2013) take a decidedly different tack and
ask whether the gut microbiota mightplay a role in this process. The microbiota
encompass a diverse population of
bacteria, archaea, and fungi populating
many body sites of their multicellular
hosts (Lozupone et al., 2012). In mam-
mals, their largest numbers are found in
the gastrointestinal tract, with the highest
concentrations present in the large intes-
tine. These microbiota directly impact
the metabolic status of their hosts (Trem-
aroli and Ba¨ckhed, 2012; Turnbaugh
et al., 2006). For instance, the composi-
tion of the gut microbial communities
regulates the energy yield from food andmodulates the levels of host- and diet-
derived products directly controlling
metabolic pathways. Thus, not surpris-
ingly, the microbiota are considered a
key determinant of metabolic disease
progression. However, the systemic
impact of local (i.e., small and large intes-
tine) pathways that are activated during
symbiotic or abnormal host-microbiota
interactions remains largely undeter-
mined. Mukherji et al. unveil a surprising
new link between the modulation of the
circadian clock in IECs of the ileum by
the microbiota and systemic metabolism.l 153, May 9, 2013 ª2013 Elsevier Inc. 741
Figure 1. The Microbiota Synchronizes the Intestinal Epithelial Clock and Corticosterone
Production
In the presence of microbiota (top), the RORa activator and the RevErba repressor have a phasic
expression in ileal epithelial cells (IECs). In the active phase, the activity of RORa is dominant, which leads
to the expression of innate immune receptors and the repressor protein E4BP4. In turn, E4BP4 represses
the Cyp11a1 enzyme and therefore results in low corticosterone production. At the same time, the
interaction between the intestinal microbiota and innate immune receptors prevents PPARa expression
and therefore the expression of RevErba. In the resting phase, the activity of RevErba is dominant, which
leads to the decreased level of the repressor protein E4BP4 and increased expression of Cyp11a1,
resulting in high corticosterone synthesis. Without microbiota (bottom), the absence of microbiota-innate
immune receptor interactions leads to a constant expression of PPARa and RevErba, which results in
hypercosterolism with profound metabolic consequences.Ileum IECs display a circadian temporal
expression of clock genes, including
RORa and RevErba, which in turn regu-
late numerous genes involved in IEC
homeostatic functions. One of the most
significant outcomes of IECs’ circadian
gene expression is their rhythmic pro-
duction of corticosterone in an HPA-
axis-independent manner. Strikingly, the
authors find that depletion of the intestinal
microbiota completely disrupts the
circadian gene expression and the phasic
production of corticosterone by the ileum,742 Cell 153, May 9, 2013 ª2013 Elsevier Incresulting in a sustained hypercorticoster-
olism with profound system conse-
quences such as hyperglycemia, insulin
resistance, and increased triglycerides
and free fatty acids. These results not
only provide an explanation for the
increased triglycerides and hypoinsuline-
mia in germ-free mice, but also add
another layer of complexity to the interac-
tions between host metabolism and the
intestinal microbiota. Indeed, it appears
that their presence assists a regulatory
network controlling the expression of.Cyp11a1, an enzyme that catalyzes the
first step in the conversion of cholesterol
into steroid hormones. This rate-limiting
step in corticosterone synthesis is regu-
lated in the IECs through the clock gene
E4BP4. The authors find that, in the pres-
ence of microbiota, this HPA- and ileal-
controlled glucocorticoid production is
cophasic. In antibiotic-treated mice, this
phasic production is, however, disrupted
due to low E4BP4 expression and the
resulting lack of Cyp11a1 repression.
But how does the intestinal microbiota
regulate IEC circadian gene expression?
A sequence of interdependent processes
determines the answer to this question
(Figure 1). Among the hundreds of genes
that are rhythmically regulated by RORa
and RevErba are multiple innate immune
receptors such as TLRs and NOD2. As a
consequence, innate immune receptor
signaling triggered by the constant expo-
sure to the host microbiota also follows a
rhythmic pattern. This rhythmic signaling
through innate immune receptors, in
turn, keeps the cogs of the IEC’s clock
synchronized by preventing the expres-
sion of the transcription factor PPARa
and also establishes the downstream
phasic production of corticosterone by
the ileal IECs. Therefore, in the absence
of cues from the microbiota, the main
cogwheel of the IEC’s clock is jammed
by the constitutive expression of PPARa,
leading to hypercorticosterolism.
Innate immune response pathways are
evolutionarily conserved throughout spe-
cies and are fundamental for survival,
and nearly all organisms have developed
mechanisms for anticipating environ-
mental changes in order to coordinate
physiological responses. Thus, it is not
surprising that complex circadian regula-
tion of innate immune receptors is starting
to be elucidated from multiple angles. For
instance, recent reports indicate that
circadian clocks control the expression
of the immune receptor TLR9 and that
adaptive immune responses can be
enhanced through immunization at times
of increased TLR9 responsiveness (Silver
et al., 2012). Thus, the elucidation of an
IEC circadian clock that regulates TLR
expression and the finding that this clock
is controlled by the presence of intestinal
microorganisms represents another step
forward in this exciting and emerging
field. Moreover, it highlights the central
role of microbiota-host interactions in
hitherto seemingly unrelated physiolog-
ical processes such as intestinal circadian
clocks and systemic metabolism.
This study leaves us with several
intriguing questions. First, which innate
immune receptors are responsible for
the regulation of the circadian clocks in
IECs? Several TLRs and other receptors
are expressed phasically, but deficiency
in the major essential adaptor for most
TLRs, MyD88, does not cause a similar
phenotype. Some TLRs, such as TLR3
and TLR4, could still signal through the
adaptor TRIF or alternative pathways
that do not require MyD88, such as
RIG-I-like receptors. A second question
is whether different types of intestinal
epithelial cells such as enterocytes,
goblet cells, paneth cells, and stem cells
differ in their regulation of the circadian
clock. An intriguing possibility would be
that one of these populations, for instance
the paneth cells, could serve as pacemakers, affecting other cellular subsets.
Moreover, in light of the large body of
recent work by groups including our
own, which link specific members of
the intestinal microbiota with metabolic
disease (Henao-Mejia et al., 2012; Turn-
baugh et al., 2006; Vijay-Kumar et al.,
2010), these findings raise the exciting
question of whether specific members
of the microbiota have exquisite abilities
to influence the circadian rhythm and
glucocorticoid synthesis. Finally, future
research should decipher the particular
importance of corticosterone produc-
tion in the ileum and the relevance of
the severe metabolic alterations associ-
ated with the disruption of this control
mechanism for both local and systemic
pathologies.REFERENCES
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In this issue of Cell, Loffredo et al. demonstrate that exposing an old mouse to the circulatory
system of a young mouse reverses age-related cardiac hypertrophy. The authors demonstrate
that this effect can be recapitulated by treating old mice with growth and differentiation factor 11
(GDF11). These data suggest that GDF11 therapy may be a useful tool in combating age-related
cardiac hypertrophy.Within the context of an increasingly aged
population, the healthcare costs associ-
ated with aging-related heart failure
represent a significant healthcare burden.
Diastolic heart failure, characterized by
impaired cardiac filling during relaxation,
in particular, is a condition lacking specific
and effective therapies (Hunt et al., 2009;
Kitzman and Daniel, 2007). Though
perhaps controversial, there appears to
be an association between an age-relatedincrease in cardiac mass (i.e., cardiac
hypertrophy) and the development of dia-
stolic dysfunction (Dai and Rabinovitch,
2009; Lakatta and Levy, 2003). Age-
related cardiac hypertrophy has been
described in humans and animal models,
but the physiological, hormonal, cellular,
and molecular causes remain poorly
understood. Here, Loffredo et al. demon-
strate that exposing an old mouse to the
circulation of a young mouse using apowerful technique called parabiosis can
reverse many of the biological conse-
quences of age-related cardiac hypertro-
phy (Loffredo et al., 2013). The authors go
on to establish that this effect appears to
be at least partially modulated by a circu-
lating protein called growth and differenti-
ation factor 11 (GDF11).
The traditional technique of parabiosis
involves joining the vasculature of two
animals such that the two animalsl 153, May 9, 2013 ª2013 Elsevier Inc. 743
